CervoMed announces July 23 virtual KOL event on neflamapimod for DLB; no new data disclosed

CervoMed Inc.

Event focused on neflamapimod for dementia with Lewy bodies.
Presentation available on company website; no material results in 8-K.
Company may reuse presentation in future investor meetings.
No forward-looking statements or financial guidance updated.

item 7.01 item 9.01

CervoMed Inc. filing history →

Source: SEC EDGAR

accession 0001437749-24-023240

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.